Amyris, a synthetic biotech company breaking into Clean Health & Beauty, is getting serious about the menopause market with the acquisition on Menolabs, who have developed line of all natural, proprietary supplements focused on treating perimenopause and menopause symptoms as well as a menopause health tracking app, and a community forum.

Amyris previously shared its intention of launching a new consumer brand to provide science-backed, wellness and personal care products for the high growth menopause market in 2022. The acquisition of MenoLabs will now serve as a catalyst to accelerate growth.

MenoLabs, a growing women’s wellness brand is focused on addressing perimenopause and menopause symptoms. Over the past two years, the company has developed and launched eight subscription-based products, including its lead product, MenoFit, an all-natural menopause relief supplement.

Menopause symptoms impact the lives of approximately 25 million women per year and 6,000 women in the U.S. enter perimenopause every day (That’s 2.2 million each year!). By 2025, there will be over one billion people experiencing menopause in the world or around 12% of the entire world population. Stigma, lack of open discussion, and a small product offering at an affordable price are barriers to care for women. The menopause market was valued at around $15 billion in 2020 and is expected to reach approximately $23 billion by 2028.

“We are very impressed with the MenoLabs offering which is synergistic with our science-based approach to real-world health and wellness issues. We are committed to empowering women and creating a platform to support them with our leading science and wellness technology platform. Women deserve products and solutions that work during this period in their lives,” said John Melo, President and Chief Executive Officer of Amyris. “Our acquisition of the products and app that the MenoLabs team has built accelerates Amyris’ entry into the menopause market. We expect the combination of MenoLabs and the previously announced menopause brand with Naomi Watts to have the potential to deliver an estimated $30 million in revenue in their first year and expect significant growth potential in the years ahead. We continue to execute on our growth strategy diversifying our consumer offering in Clean Beauty, Health and Wellness end-markets, continuing the strong growth momentum from 2021 into the current quarter.”

Show CommentsClose Comments

Leave a comment